VSee Health, Inc. Deferred Income Tax Expense (Benefit)
VSee Health, Inc. (VSEE) reported Deferred Income Tax Expense (Benefit) of $51.81 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-31
- VSee Health, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $51.81K.
- VSee Health, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- VSee Health, Inc. deferred income tax expense (benefit) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. deferred income tax expense (benefit) for the quarter ending 2024-09-30 was $0.00.
- VSee Health, Inc. deferred income tax expense (benefit) for fiscal 2025 was $51.81K.
- VSee Health, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$1.68M, a 190.64% decline from fiscal 2023.
- VSee Health, Inc. deferred income tax expense (benefit) for fiscal 2023 was $1.85M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $51.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $51.81K derived: sum of 2 quarters · filed 2026-03-31 | $51.81K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $0.00 10-Q/A · filed 2025-11-20 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | -$1.68M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$1.68M 10-Q · filed 2025-11-14 | -$2.34M 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$1.68M 10-Q/A · filed 2025-11-20 | -$2.34M 10-Q · filed 2024-09-23 | ||||
| 2023-12-31 | $2.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $2.21M derived: sum of 2 quarters · filed 2025-08-29 | $1.85M 10-K/A · filed 2025-08-29 | |||
| 2023-09-30 | -$233.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$590.95K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | -$357.24K 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |